Partnering with BI Sincerely, Yours - Boehringer Ingelheim
Partnering with BI Sincerely, Yours - Boehringer Ingelheim
Partnering with BI Sincerely, Yours - Boehringer Ingelheim
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A strategic intent to partnering,<br />
commercial expertise and unique culture<br />
will underpin our alliance<br />
What is <strong>Boehringer</strong> <strong>Ingelheim</strong><br />
looking for ?<br />
The search for new therapeutic options forms<br />
the cornerstone of research and development<br />
at <strong>Boehringer</strong> <strong>Ingelheim</strong>. We aim to contribute<br />
to therapeutic progress by developing tomorrow’s<br />
cures from today’s science.<br />
For us, partnering is key to success in this mission.<br />
It is central to our company strategy and<br />
forms an integral part of our drug discovery<br />
and development efforts.<br />
Value through Innovation<br />
…the most innovative technologies and therapeutic principles at all stages from<br />
research and development to commercialization.<br />
Content:<br />
• Cardiometabolic Diseases 6<br />
• Central Nervous System 8<br />
• Commercial Opportunities/Other 10<br />
• External Outreach 12<br />
• Immunology/Inflammation 14<br />
• Infectious Diseases 16<br />
• Oncology 18<br />
• Respiratory 20<br />
• Contacts for Asia/Japan 22<br />
• Contacts for Asia/China 24<br />
• Contacts for Strategic Transactions<br />
and Alliance Management 26<br />
2 1<br />
Updated June 2011
Change language